Platelet recovery delay and survival in patients with myelofibrosis undergoing allogeneic hemopoietic stem cell transplantation
We studied platelet recovery in 93 patients with myelofibrosis, following an allogeneic hemopoietic stem cell transplant (HSCT). The primary end point of the study was achieving a platelet count of 50x10^9/L within day +100, which occurred in 62 patients (67%) and predicted 5 year non relapse mortality (5% vs 55%; p=0.0009) and 5 year actuarial survival (85% vs 38%; p=.
Authors
- eugenio galli
- E. Metafuni
- Filippo Frioni (ORCID: https://orcid.org/0000-0002-8427-2788)
- Maria Assunta Limongiello (ORCID: https://orcid.org/0000-0001-7802-8554)
- sabrina giammarco
- Patrizia Chiusolo (ORCID: https://orcid.org/0000-0002-1355-1587)
- A. Bacigalupo
- Federica Sora'
- Simona Sica
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Agostino Gemelli University Polyclinic (IT)
Publication Details
- Journal
- Haematologica
- Published
- 2026-01-15
- DOI
- https://doi.org/10.3324/haematol.2025.288371
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Associazione Italiana per la Ricerca sul Cancro